Bogart KR, Tickle-Degnen L, Ambady N Compensatory expressive behavior for facial paralysis: adaptation to congenital or acquired disability. Rehabil Psychol. 2012 Feb;57(1):43-51. doi: 10.1037/a0026904.
Bogart KR, Tickle-Degnen L, Joffe MS Social interaction experiences of adults with Moebius Syndrome: a focus group. J Health Psychol. 2012 Nov;17(8):1212-22. doi: 10.1177/1359105311432491. Epub 2012 Jan 18.
Bogart KR Is apathy a valid and meaningful symptom or syndrome in Parkinson's disease? A critical review. Health Psychol. 2011 Jul;30(4):386-400. doi: 10.1037/a0022851. Review.
Davis LL, Weaver M, Habermann B Differential attrition in a caregiver skill training trial. Res Nurs Health. 2006 Oct;29(5):498-506.
Duncan RP, Earhart GM Measuring participation in individuals with Parkinson disease: relationships with disease severity, quality of life, and mobility. Disabil Rehabil. 2011;33(15-16):1440-6. doi: 10.3109/09638288.2010.533245. Epub 2010 Nov 20.
Eagly AH The his and hers of prosocial behavior: an examination of the social psychology of gender. Am Psychol. 2009 Nov;64(8):644-58. doi: 10.1037/0003-066X.64.8.644.
Everard KM, Lach HW, Fisher EB, Baum MC Relationship of activity and social support to the functional health of older adults. J Gerontol B Psychol Sci Soc Sci. 2000 Jul;55(4):S208-12.
Glasgow RE, Strycker LA, Toobert DJ, Eakin E A social-ecologic approach to assessing support for disease self-management: the Chronic Illness Resources Survey. J Behav Med. 2000 Dec;23(6):559-83.
Gunnery SD, Naumova EN, Saint-Hilaire M, Tickle-Degnen L Mapping spontaneous facial expression in people with Parkinson's disease: A multiple case study design. Cogent Psychol. 2017;4. pii: 1376425. doi: 10.1080/23311908.2017.1376425. Epub 2017 Sep 8.
Habermann B, Davis LL Caring for family with Alzheimer's disease and Parkinson's disease: needs, challenges and satisfaction. J Gerontol Nurs. 2005 Jun;31(6):49-54.
Habermann B Continuity challenges of Parkinson's disease in middle life. J Neurosci Nurs. 1999 Aug;31(4):200-7.
Harezlak J, Naumova E, Laird NM LongCriSP: a test for bump hunting in longitudinal data. Stat Med. 2007 Mar 15;26(6):1383-97.
Hemmesch AR, Tickle-Degnen L, Zebrowitz LA The influence of facial masking and sex on older adults' impressions of individuals with Parkinson's disease. Psychol Aging. 2009 Sep;24(3):542-9. doi: 10.1037/a0016105.
Holman HR, Lorig KR Overcoming barriers to successful aging. Self-management of osteoarthritis. West J Med. 1997 Oct;167(4):265-8. Review.
Holt-Lunstad J, Smith TB, Layton JB Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010 Jul 27;7(7):e1000316. doi: 10.1371/journal.pmed.1000316. Review.
Hunt SM, McEwen J The development of a subjective health indicator. Sociol Health Illn. 1980 Nov;2(3):231-46. Review.
Jenkinson C , Fitzpatrick R., Peto V., Greenhall R. and Hyman N. (1997). The PDQ-8: Development and validation of a short-form Parkinson?s disease questionnaire. Psychology and Health, 12, 805-814.
Karlsen KH, Tandberg E, Arsland D, Larsen JP Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):584-9.
Litwin H Social networks and well-being: a comparison of older people in Mediterranean and non-Mediterranean countries. J Gerontol B Psychol Sci Soc Sci. 2010 Sep;65(5):599-608. doi: 10.1093/geronb/gbp104. Epub 2009 Dec 14.
Lyons KD, Tickle-Degnen L Reliability and validity of a videotape method to describe expressive behavior in persons with Parkinson's disease. Am J Occup Ther. 2005 Jan-Feb;59(1):41-9.
Martinez LS, Rubin CL, Russell B, Leslie LK, Brugge D Community conceptualizations of health: implications for transdisciplinary team science. Clin Transl Sci. 2011 Jun;4(3):163-7. doi: 10.1111/j.1752-8062.2011.00289.x.
Naumova EN, Must A, Laird NM Tutorial in Biostatistics: Evaluating the impact of 'critical periods' in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol. 2001 Dec;30(6):1332-41.
Netuveli G, Wiggins RD, Montgomery SM, Hildon Z, Blane D Mental health and resilience at older ages: bouncing back after adversity in the British Household Panel Survey. J Epidemiol Community Health. 2008 Nov;62(11):987-91. doi: 10.1136/jech.2007.069138.
Nolte S, Elsworth GR, Sinclair AJ, Osborne RH The extent and breadth of benefits from participating in chronic disease self-management courses: a national patient-reported outcomes survey. Patient Educ Couns. 2007 Mar;65(3):351-60. Epub 2006 Oct 5.
Pennebaker, J W., Booth, R. J. & Francis, M. E., & (2007). Linguistic Inquiry and Word Count (LIWC). [Computer software]. Austin, TX: LIWC.net.
Peto V, Jenkinson C, Fitzpatrick R PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol. 1998 May;245 Suppl 1:S10-4.
Pinquart M, Sörensen S Influences of socioeconomic status, social network, and competence on subjective well-being in later life: a meta-analysis. Psychol Aging. 2000 Jun;15(2):187-224.
Roger KS, Medved MI Living with Parkinson's disease-managing identity together. Int J Qual Stud Health Well-being. 2010 Mar 30;5. doi: 10.3402/qhw.v5i2.5129.
Sarkar R, Ajjampur SS, Ward HD, Kang G, Naumova EN Analysis of human immune responses in quasi-experimental settings: tutorial in biostatistics. BMC Med Res Methodol. 2012 Jan 3;12:1. doi: 10.1186/1471-2288-12-1.
Schulman EA, Hohler AD The American Academy of Neurology position statement on abuse and violence. Neurology. 2012 Feb 7;78(6):433-5. doi: 10.1212/WNL.0b013e318245d21c. Epub 2012 Jan 25.
Sheikh, J , & Yesavage, J. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. In T.L. Brink (Ed.), Clinical Gerontology: A guide to assessment and intervention (pp. 165-173). New York: Haworth Press.
Sunvisson H, Habermann B, Weiss S, Benner P Augmenting the Cartesian medical discourse with an understanding of the person's lifeworld, lived body, life story and social identity. Nurs Philos. 2009 Oct;10(4):241-52. doi: 10.1111/j.1466-769X.2009.00413.x.
Tickle-Degnen L, Lyons KD Practitioners' impressions of patients with Parkinson's disease: the social ecology of the expressive mask. Soc Sci Med. 2004 Feb;58(3):603-14.
Tickle-Degnen L, Zebrowitz LA, Ma HI Culture, gender and health care stigma: Practitioners' response to facial masking experienced by people with Parkinson's disease. Soc Sci Med. 2011 Jul;73(1):95-102. doi: 10.1016/j.socscimed.2011.05.008. Epub 2011 May 25.
Ware J Jr, Kosinski M, Keller SD A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220-33.
World Health Organization (2001). International Classification of Functioning, Disability and Health (ICF). Geneva: Author.
Worth A, Tierney AJ Conducting research interviews with elderly people by telephone. J Adv Nurs. 1993 Jul;18(7):1077-84.
Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143-51. doi: 10.1159/000275491. Epub 2010 Jan 15.
The Emergence and Evolution of Social Self-Management of Parkinson's Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.